Ironwood Pharmaceuticals, Inc. - (IRWD): Price and Financial Metrics
IRWD Price/Volume Stats
Current price | $9.63 | 52-week high | $12.66 |
Prev. close | $9.55 | 52-week low | $8.07 |
Day low | $9.54 | Volume | 1,876,300 |
Day high | $9.77 | Avg. volume | 2,343,727 |
50-day MA | $9.66 | Dividend yield | N/A |
200-day MA | $10.69 | Market Cap | 1.50B |
IRWD Stock Price Chart Interactive Chart >
IRWD POWR Grades
- Quality is the dimension where IRWD ranks best; there it ranks ahead of 93.8% of US stocks.
- IRWD's strongest trending metric is Quality; it's been moving down over the last 177 days.
- IRWD ranks lowest in Sentiment; there it ranks in the 9th percentile.
IRWD Stock Summary
- With a one year PEG ratio of 0.34, IRONWOOD PHARMACEUTICALS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than merely 4.81% of US stocks.
- Of note is the ratio of IRONWOOD PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; just 3.59% of US stocks have a lower such ratio.
- Over the past twelve months, IRWD has reported earnings growth of -464.36%, putting it ahead of just 3.16% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to IRONWOOD PHARMACEUTICALS INC are SM, MMAT, MRO, KOS, and ADV.
- IRWD's SEC filings can be seen here. And to visit IRONWOOD PHARMACEUTICALS INC's official web site, go to www.ironwoodpharma.com.
IRWD Valuation Summary
- IRWD's price/sales ratio is 3.4; this is 15% lower than that of the median Healthcare stock.
- Over the past 166 months, IRWD's price/sales ratio has gone down 28.8.
Below are key valuation metrics over time for IRWD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
IRWD | 2023-09-22 | 3.4 | -4.2 | -1.6 | -2.4 |
IRWD | 2023-09-21 | 3.4 | -4.2 | -1.6 | -2.4 |
IRWD | 2023-09-20 | 3.4 | -4.1 | -1.6 | -2.4 |
IRWD | 2023-09-19 | 3.4 | -4.2 | -1.6 | -2.4 |
IRWD | 2023-09-18 | 3.1 | -3.9 | -1.5 | -2.3 |
IRWD | 2023-09-15 | 3.0 | -3.8 | -1.4 | -2.3 |
IRWD Growth Metrics
- Its 4 year cash and equivalents growth rate is now at 72.77%.
- The 5 year price growth rate now stands at -33.93%.
- Its 3 year cash and equivalents growth rate is now at 394.3%.

The table below shows IRWD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 410.596 | 273.763 | 175.065 |
2022-09-30 | 420.527 | 259.149 | 167.572 |
2022-06-30 | 415.637 | 265.122 | 173.1 |
2022-03-31 | 422.437 | 252.325 | 527.323 |
2021-12-31 | 413.753 | 261.895 | 528.448 |
2021-09-30 | 413.303 | 248.84 | 530.278 |
IRWD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- IRWD has a Quality Grade of B, ranking ahead of 94.53% of graded US stocks.
- IRWD's asset turnover comes in at 0.622 -- ranking 50th of 682 Pharmaceutical Products stocks.
- LGND, COLL, and OMER are the stocks whose asset turnover ratios are most correlated with IRWD.
The table below shows IRWD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.622 | 0.998 | 0.305 |
2021-03-31 | 0.761 | 0.998 | 0.286 |
2020-12-31 | 0.820 | 0.992 | 0.226 |
2020-09-30 | 0.916 | 0.967 | 0.230 |
2020-06-30 | 1.077 | 0.976 | 0.213 |
2020-03-31 | 1.207 | 0.951 | 0.198 |
IRWD Price Target
For more insight on analysts targets of IRWD, see our IRWD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $13.83 | Average Broker Recommendation | 1.71 (Moderate Buy) |
Ironwood Pharmaceuticals, Inc. - (IRWD) Company Bio
Ironwood Pharmaceuticals engages in the research, development, and commercialization of human therapeutic products, with a key focus being the treatment of adult men and women suffering from irritable bowel syndrome. The company was founded in 1998 and is based in Cambridge, Massachusetts.
Latest IRWD News From Around the Web
Below are the latest news stories about IRONWOOD PHARMACEUTICALS INC that investors may wish to consider to help them evaluate IRWD as an investment opportunity.
Here's How to Lock in a Trade on a Promising Biopharma NameThis small-cap is developing a promising new gastrointestinal disease-fighting drug and has one already on the market, making it a great options play. |
Unveiling Ironwood Pharmaceuticals (IRWD)'s Value: Is It Really Priced Right? A Comprehensive GuideUnderstanding the intrinsic value and financial strength of Ironwood Pharmaceuticals |
Ironwood (IRWD) Surges 7.6%: Is This an Indication of Further Gains?Ironwood (IRWD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. |
Ironwood Pharmaceuticals Inc (IRWD): A Deep Dive into Its Performance PotentialUnraveling the Factors That Could Limit Ironwood Pharmaceuticals Inc's Outperformance |
Ironwood Pharmaceuticals (IRWD): A Comprehensive Analysis of Its Market ValueIs the stock modestly undervalued? Let's delve into the details. |
IRWD Price Returns
1-mo | 4.00% |
3-mo | N/A |
6-mo | -8.72% |
1-year | -7.05% |
3-year | 3.49% |
5-year | -50.00% |
YTD | -22.28% |
2022 | 6.26% |
2021 | 2.37% |
2020 | -14.43% |
2019 | 28.47% |
2018 | -30.89% |
Continue Researching IRWD
Here are a few links from around the web to help you further your research on Ironwood Pharmaceuticals Inc's stock as an investment opportunity:Ironwood Pharmaceuticals Inc (IRWD) Stock Price | Nasdaq
Ironwood Pharmaceuticals Inc (IRWD) Stock Quote, History and News - Yahoo Finance
Ironwood Pharmaceuticals Inc (IRWD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...